JPRN-UMIN000013247
Completed
Phase 2
A phase II feasibility study of surgical intervention for single station cN2 (UICC 6) non-small cell lung cancer (JNETS 0801) - Feasibility study of surgery for single station cN2
Japan North-East Area Thoracic Oncology Study Group0 sites34 target enrollmentFebruary 24, 2014
Conditionson-small cell lung cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- on-small cell lung cancer
- Sponsor
- Japan North-East Area Thoracic Oncology Study Group
- Enrollment
- 34
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Mediastinal lymphnodes with above 20mm in their shorter diameter. cN2 with over 2 stations. General contraindication for the thoracotomy with low cardio\-pulmonary function, liver or renal dysfunction and the others. Age over 76\. Extra\-nodal invation of cN2 nodes. Distant metastasis. Other malignancies. \#1\-3(UICC 6\) lymphnodes swelling in left side mediastinum. preceding hemotherapy, molecular targetting therapy, thoracic radiotherapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Phase II clinical trial of surgical intervention following chemotherapy for synchronous and metachronous liver metastasis from gastric cancer.Patients with synchronous or metachronous liver metastasis from gastric cancerJPRN-UMIN000011445Department of Surgery, Osaka University Graduate School of Medicine50
Recruiting
Phase 2
Phase II clinical trial of surgical intervention following chemotherapy for synchronous and metachronous liver metastasis from gastric cancer.(HiSCO 06)Patients with synchronous or metachronous liver metastasis from gastric cancerJPRN-UMIN000024004Hiroshima Surgical Study group of Clinical Oncology (HiSCO)30
Completed
Phase 2
Phase2 study of limited Surgery for T1 or T2 lower rectal Cancer with adjuvant chemoradiotherapyRectal cancerJPRN-UMIN000007184Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group50
Recruiting
Phase 2
Atezolizumab Combined With Platinum-based Chemotherapy as Neoadjuvant Therapy for Patients With Resectable Stage II-IIIBNon Small Cell Lung CancerNCT05295212Hunan Province Tumor Hospital120
Active, not recruiting
Phase 1
Clinical study to assess the safety and preliminary efficacy of HCR040, a drug based on mesenchymal stem cells, in patients with acute respiratory distress syndrome. (included patients COVID-19)acute respiratory distress syndromeTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2019-002688-89-ESHistocell S.L.26